Delivery Order SPE2DB24D6044-SPE2DB25FLJLR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units, valued at $2,502.11. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract was executed with an ultimate completion date of September 4, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,512.56 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 19, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation, reflecting AmerisourceBergen's competitive standing in federal...
- The Defense Logistics Agency awarded a $1,941.77 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram units. This firm fixed price, non-set-aside contract is scheduled for completion by August 27, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Naftifine HCL 1% Cream in 60-gram quantities, with a ceiling value of $1,625.15 and a completion date of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA Troop Support Medical. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,935.92 to AmerisourceBergen Drug Corp for Naftifine HCL 2% Gel 60GM, a topical antifungal medication. The contract was competitively awarded without set-aside designation and is classified as a firm fixed price delivery order, with an ultimate completion date of May 21, 2025. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,939.04 to AmerisourceBergen Drug Corp for Naftifine HCL 2% Gel in 45-gram units. This competitively awarded, firm fixed-price delivery order was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. The contract carries no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $6,904.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Naftifine HCL 1% Cream in 60-gram quantities. The contract, which is non-set-aside and competitively awarded, specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 16, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the delivery of Naftifine Hydrochloride 1% Cream, a topical antifungal medication, in 90-gram tubes. The $1,859.50 firm fixed price delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,025.12 fixed-price delivery order is for the supply of Naftifine Hydrochloride 1% Cream (60 grams), a topical antifungal medication. The award is not associated with a set-aside program and is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Naftifine HCL 1% Cream, a topical antifungal medication, with a ceiling value of $3,602.31 and a completion date of April 8, 2025. The contract is a firm fixed-price agreement, with no set-aside designation, indicating open competition. Amerisourcebergen...
- SPE2DB24D6044Indefinite Delivery Contract
- SPE2DB24D6044-SPE2DB25FLJLRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,128.62 to AmerisourceBergen Drug Corp for Naftifine HCL 2% Cream in 45-gram units. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 8, 2025. The award was issued on September 5, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of medications, vaccines, and medical supplies to support military healthcare programs globally. Naftifine HCL cream is a topical antifungal medication commonly used for fungal skin infections, consistent with the contractor's extensive portfolio of pharmaceutical products supporting Defense Health Agency and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 9/5/25 |